Fresh with a rebrand, Cyllene will advance gene therapies built on a platform that uses a modified form of the herpes virus ...

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock ...

In the latest close session, Merck (MRK) was down 2.15% at $126.78. This change lagged the S&P 500's 0.72% gain on the day. On the other hand, the Dow registered a gain of 0.3%, and the ...

By Christy Santhosh, Padmanabhan Ananthan and Bhanvi Satija June 25 (Reuters) - German drugmaker Merck KGaA said on Thursday ...

In March, Merck & Co Inc. MRK agreed to acquire Terns Pharmaceuticals Inc. TERN, as the U.S. drugmaker accelerates efforts to offset looming revenue risks tied to its blockbuster cancer immunotherapy ...

RAHWAY, N.J. and FOSTER CITY, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: ...

April 24 (Reuters) - Germany's Merck KGaA (MRCG.DE), opens new tab said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics (SWTX.O), opens new tab for about $3.5 ...

RAHWAY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Orna Therapeutics, a biotechnology company pioneering a new investigational ...

Merck stock has shown some solid short-term strength, with its stock price of $98.90 comfortably sitting above its eight-day and 20-day simple moving averages (SMAs) of $97.81 and $98.64, respectively ...

Johnson & Johnson is a global leader in the pharmaceutical and medical device industries. Its key products include ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that the companies ...